Selected References:
- Benyamini L, et al. 2005. The safety of amoxicillin/clavulanic acid and cefuroxime during lactation. Ther Drug Monit. 27:499–502.
- Chu YN, et al. 2019. Toxic epidermal necrolysis in an infant induced by drug intake through breast milk. Dermatologica Sinica. 37:86–89.
- Czeizel AE, et al. 2001. Use of cephalosporins during pregnancy and in the presence of congenital anomalies: a population-based, case-control study. Am J Obstet Gynecol 184:1289-1896.
- Ilett KF, et al. 2006. Transfer of probenecid and cephalexin into breast milk. Ann Pharmacother. 40:986–989.
- Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 168:1393–1399.
- Kafetzi D, et al. 1981. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand 70:285-288.
- Teva Pharmaceuticals. 2020. Cephalexin product label. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19307ff0-71de-477b-965d-ea243e5ede3a. [Accessed March 27 2024]
